Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '25 Aug 1, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	10	12	114	251	-
Market Cap Growth	-0.18%	-89.74%	-54.54%	-	-
Enterprise Value	24	27	128	-	-
Last Close Price	0.25	1.10	10.37	9.86	-
PS Ratio	0.12	0.18	2.12	5.13	-
PB Ratio	-	-0.36	-3.95	-9.52	-
P/FCF Ratio	15.71	2.35	21.34	-	-
P/OCF Ratio	8.83	2.26	20.78	-	-
EV/Sales Ratio	0.35	0.42	2.37	-	-
EV/EBITDA Ratio	-	-	69.21	-	-
EV/EBIT Ratio	-	-	71.77	-	-
EV/FCF Ratio	36.92	5.42	23.94	-	-
Debt / Equity Ratio	-0.40	-0.14	-0.09	-0.89	-1.06
Debt / EBITDA Ratio	-	22.79	0.76	-	-
Debt / FCF Ratio	22.92	0.90	0.49	-	-
Asset Turnover	2.15	1.91	1.64	1.35	-
Inventory Turnover	4.50	5.47	4.87	3.14	-
Quick Ratio	0.25	0.33	0.43	0.39	0.48
Current Ratio	0.51	0.60	0.69	0.52	0.78
Return on Assets (ROA)	-4.63%	-3.49%	3.40%	-15.82%	-
Earnings Yield	-99.82%	-72.00%	-0.89%	-4.79%	-
FCF Yield	6.37%	42.55%	4.69%	-0.59%	-
Buyback Yield / Dilution	-214.87%	-5.53%	2.16%	-	-

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q